Literature DB >> 22806056

Structured clinical assessment of the ear, nose and throat in patients with granulomatosis with polyangiitis (Wegener's).

Marcos Martinez Del Pero1, Niels Rasmussen, Afzal Chaudhry, Piyush Jani, David Jayne.   

Abstract

The objective of this prospective cross-sectional study is to describe the clinical otorhinolaryngological manifestations of granulomatosis with polyangiitis (Wegener's) (GPA) in a prospective cohort. All patients suffering from GPA seen in a tertiary centre between March 2007 and November 2008 had a detailed clinical assessment by an ENT surgeon of their ear, nose and head and neck complaints. An evaluation of whether there was disease activity and/or infection in each ENT area was made using the European Vasculitis Study Group guidelines. The number of patients assessed was 144. The proportion of female patients was 47 % (n = 69) and the median age was 57.7 years (IQ range 42.5-68.5). The prevalence of ENT involvement was 87 % (125/144). Hearing loss and abnormal tympanic membrane appearance were more common in patients with active disease and no infection (7/8 and 6/8, respectively, in active disease cf. 59/131 and 52/131, respectively, in remission). Nasal crusting was the most common nasal complaint recorded (52/144, 36 %) and bloody rhinorrhoea was the most common symptom in patients with disease activity. Rhinoscopy was highly sensitive in diagnosing disease activity (100 %). Subglottic stenosis was the most common head and neck manifestation (27/121, 22 %) and 74 % were symptomatic. In conclusion, the pattern and frequency of clinical ENT manifestations in GPA have been described in a large patient cohort. The use of tools readily available in the ENT clinic was essential to assess these patients accurately. This dataset will form the basis of an objective scoring system to measure disease activity in the ENT system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22806056     DOI: 10.1007/s00405-012-2110-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  35 in total

1.  Surgical management of nasolacrimal duct obstruction in patients with Wegener's granulomatosis.

Authors:  P W Hardwig; G B Bartley; J A Garrity
Journal:  Ophthalmology       Date:  1992-01       Impact factor: 12.079

2.  Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides.

Authors:  A R Exley; P A Bacon; R A Luqmani; G D Kitas; C Gordon; C O Savage; D Adu
Journal:  Arthritis Rheum       Date:  1997-02

3.  Primary systemic vasculitis: clinical features and mortality.

Authors:  S E Lane; R A Watts; L Shepstone; D G I Scott
Journal:  QJM       Date:  2005-01-17

4.  Lessons learnt in the management of Wegener's Granulomatosis: long-term follow-up of 60 patients.

Authors:  E L Sproson; N S Jones; M Al-Deiri; P Lanyon
Journal:  Rhinology       Date:  2007-03       Impact factor: 3.681

5.  An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients.

Authors:  E Reinhold-Keller; N Beuge; U Latza; K de Groot; H Rudert; B Nölle; M Heller; W L Gross
Journal:  Arthritis Rheum       Date:  2000-05

6.  Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis.

Authors:  C A Langford; M C Sneller; C W Hallahan; G S Hoffman; W A Kammerer; C Talar-Williams; A S Fauci; R S Lebovics
Journal:  Arthritis Rheum       Date:  1996-10

7.  Hearing loss in Wegener's granulomatosis.

Authors:  Sivasanker Bakthavachalam; Mark S Driver; Clarke Cox; Jeffrey H Spiegel; Kenneth M Grundfast; Peter A Merkel
Journal:  Otol Neurotol       Date:  2004-09       Impact factor: 2.311

Review 8.  Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee.

Authors:  G Anderson; E T Coles; M Crane; A C Douglas; A R Gibbs; D M Geddes; E T Peel; J B Wood
Journal:  Q J Med       Date:  1992-06

9.  Long-term follow-up of repair of external nasal deformities in patients with Wegener's granulomatosis.

Authors:  David Congdon; David A Sherris; Ulrich Specks; Thomas McDonald
Journal:  Laryngoscope       Date:  2002-04       Impact factor: 3.325

10.  Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.

Authors:  John H Stone
Journal:  Arthritis Rheum       Date:  2003-08
View more
  14 in total

1.  A clinical threat in patients with granulomatosis polyangiitis in remission: Subglottic stenosis.

Authors:  Yunus Ugan; Atalay Doğru; Giray Aynalı; Mehmet Şahin; Şevket Ercan Tunç
Journal:  Eur J Rheumatol       Date:  2017-04-11

2.  Granulomatosis with polyangiitis causing subglottic stenosis-two cases and their management.

Authors:  Victoria Blackabey; Richard Wei Chern Gan; Helen Buglass; Veena Kaul; Victoria M M Ward
Journal:  AME Case Rep       Date:  2018-04-30

3.  Increased histopathological yield for granulomatosis with polyangiitis based on nasal endoscopy of suspected active lesions.

Authors:  Olga Beltrán Rodríguez-Cabo; Edgardo Reyes; Jorge Rojas-Serrano; Luis Felipe Flores-Suárez
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-11       Impact factor: 2.503

4.  Ear, nose and throat involvement in granulomatosis with polyangiitis: how it presents and how it determines disease severity and long-term outcomes.

Authors:  Mara Felicetti; Diego Cazzador; Roberto Padoan; Alfonso Luca Pendolino; Chiara Faccioli; Ennio Nardello; Alvise Berti; Marina Silvestrini; Giuseppe Paolazzi; Giuliano Brunori; Elisabetta Zanoletti; Enzo Emanuelli; Alessandro Martini; Franco Schiavon
Journal:  Clin Rheumatol       Date:  2018-02-20       Impact factor: 2.980

Review 5.  Granuloma in ANCA-associated vasculitides: another reason to distinguish between syndromes?

Authors:  Antje Mueller; Konstanze Holl-Ulrich; Wolfgang L Gross
Journal:  Curr Rheumatol Rep       Date:  2013-11       Impact factor: 4.592

6.  Prevalence of hearing impairment in patients with rheumatoid arthritis, granulomatosis with polyangiitis (GPA, Wegener's granulomatosis), or systemic lupus erythematosus.

Authors:  Torsten Rahne; Franziska Clauß; Stefan K Plontke; Gernot Keyßer
Journal:  Clin Rheumatol       Date:  2017-04-28       Impact factor: 2.980

7.  Factors Affecting Dilation Interval in Patients With Granulomatosis With Polyangiitis-Associated Subglottic and Glottic Stenosis.

Authors:  Lena W Chen; Ioan Lina; Kevin Motz; Alexandra J Berges; Rafael Ospino; Philip Seo; Alexander T Hillel
Journal:  Otolaryngol Head Neck Surg       Date:  2021-04-13       Impact factor: 3.497

8.  Ear, nose, throat and airways disease in granulomatosis with polyangiitis.

Authors:  Matthew L Coates; Lisa C Willcocks; Pasupathy Sivasothy; Marcos Martinez Del Pero
Journal:  Rheumatology (Oxford)       Date:  2021-06-17       Impact factor: 7.046

9.  Development of CT-based methods for longitudinal analyses of paranasal sinus osteitis in granulomatosis with polyangiitis.

Authors:  Sigrun Skaar Holme; Jon Magnus Moen; Karin Kilian; Hilde Haukeland; Øyvind Molberg; Heidi B Eggesbø
Journal:  BMC Med Imaging       Date:  2019-02-04       Impact factor: 1.930

10.  Otologic Manifestations and Progression in Patients with Wegener's granulomatosis: A Survey in 55 Patients.

Authors:  Ali Safavi Naini; Jahangir Ghorbani; Sima Montazer Lotfe Elahi; Mohsen Beigomi
Journal:  Iran J Otorhinolaryngol       Date:  2017-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.